Ogata, Masatomo
Sumi, Hirofumi
Shiizaki, Kazuhiro
Tominaga, Naoto http://orcid.org/0000-0002-3699-7418
Article History
Received: 8 March 2023
Accepted: 10 April 2023
First Online: 19 April 2023
Declarations
:
: Naoto Tominaga received honorariums from Astellas Pharmaceutical Inc. and Daiichi Sankyo Co., Ltd., for being a speaker on drugs not mentioned in this letter to the editor. Masatomo Ogata, Hirofumi Sumi, and Kazuhiro Shiizaki have no conflicts of interest to declare.
: This article does not contain any studies with human participants performed by any of the authors, since this is a Letter to the Editor.